An interventional study of Prevena vac in Obesity, Diabetes and Peripheral Vascular Disease, sponsored by Dr. Jean E. Starr, MD. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-25.
Sponsored by Dr. Jean E. Starr, MD · Not applicable, Interventional, and Treatment
The purpose of the study is to determine the effects of Prevena therapy on decreasing groin surgical site infections in patients who are obese and /or diabetic having vascular surgery.
Patients who are obese and/or diabetic may have poor surgical healing and infection rates higher. The PREVENA therapy will be used to evaluate possible reduction of infection rates in this patient population
6,570 studies on the registry are indexed under Obesity; 1,718 are open to participants now.
This study's enrollment of 276 is above the median of 77 across 5,084 interventional studies indexed under Obesity.
Browse Obesity studies →This is the only study on the registry with Dr. Jean E. Starr, MD as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
single arm study- randomized Prevena vac or standard of care
Device: Prevena vac
Also known as: randomized 1:1 negative pressure dressing vs. standard of care
number of patients with infections
reduction of 30 day surgical site infection by evaluating infection rates in obese, diabetic patients who were randomized to Prevena Vac vs. standard of care
Time frame: 30 day post surgical procedure
infection rates
reduction of 1 year graft infection in prosthetic grafts and reduction of secondary hospitalizations for infection.Patients will be followed through 1 year to measure results of infection rates and secondary hospitalization related to infection
Time frame: 1 year
This study is status unknown, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.